EllenRx®Allergy/Immunology

Xolair denied by insurance? What insurers ask for and how to appeal

omalizumab · Sources reviewed Nov 10, 2026 · Sources below

Used for
4 conditions (see above)
How it's given
Injection under the skin
Prior authorization usually required?
Varies by plan

What does my insurer usually ask for before approving Xolair?

  • For asthma, nasal polyps or food allergy: IgE blood testPlans ask for a total IgE blood test (often at least 30 IU/mL) because the label uses it with your weight to set the dose.
  • For asthma: positive allergy skin or blood testXolair is approved for allergic asthma, so plans want a test showing you react to a year-round allergen like dust mites or pet dander.
  • For asthma: still uncontrolled on daily inhalersPlans want proof your asthma stayed uncontrolled even while using a steroid inhaler plus another controller medicine.
  • For chronic hives: tried allergy pills firstPlans want to see that daily antihistamine pills, often at higher doses, did not control your hives.
  • For nasal polyps: tried a steroid nasal sprayPlans want proof that a steroid nasal spray did not work well enough, and they expect you to keep using it with Xolair.
  • Prescribed by or with a specialistPlans usually want an allergist, lung doctor, skin doctor, or ear, nose, and throat doctor to prescribe or advise.

Typical first approval: Often 4 to 12 months at first

Based on published policies from several large commercial insurers and the FDA label (see Sources). Medicare, Medicaid and other plans may use different rules. Your plan's rules may differ.

Why was Xolair denied, and what can I do?

  1. Decode your denial letter: Ellen explains the reason in plain words.
  2. Check your denial type and your rights (Medicare or Medicaid if that's your coverage).
  3. Build your appeal, with the step-by-step appeal guide.
Decode my Xolair denial

How can I lower the cost of Xolair?

If you have Medicare or Medicaid, check each program's terms before you apply.

Safety information

From FDA-approved prescribing information for Xolair (Anti-IgE Monoclonal Antibody).

Do not use if

  • Severe hypersensitivity to omalizumab

Key warnings

  • Anaphylaxis reported: observe patients after injection (typically 2 hours for first 3 doses, then 30 minutes)
  • Malignancy observed at slightly higher rates in clinical trials (causality not established)
  • Do not abruptly discontinue corticosteroids when starting

This is not a complete list. See the full Xolair prescribing information or ask your pharmacist for complete safety information.

For clinicians: Xolair prior authorization card (printable).

Sources: FDA prescribing information for Xolair (DailyMed) and these insurers' published policies: Aetna (CPB 0670, last review 08/21/2026), Anthem/Elevance (Publish date 07/01/2025; revised 05/16/2025), Cigna (Effective 7/15/2026), UnitedHealthcare (Effective 11/1/2026). Checked 2026-11-10. Sources reviewed Nov 10, 2026.

Not medical advice. This page is for educational and informational purposes only. It does not replace professional medical judgment. Always consult your prescribing physician or pharmacist before starting, stopping, or changing any medication. Ellen does not provide medical advice, diagnose conditions, or recommend treatments. Coverage rules vary by plan and change often; confirm with your plan's current policy.